August 26, 2022
Sema4 Appoints Healthcare and Diagnostics Industry Veteran Kevin Feeley as Chief Financial Officer
August 15, 2022
Sema4 Announces Continued Restructuring, Business Highlights, and Reports Second Quarter 2022 Financial Results
August 15, 2022
Sema4 Announces Changes to its Research & Development Leadership
July 26, 2022
Sema4 to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022
June 14, 2022
Sema4 Announces Chief Financial Officer Transition Plan
June 1, 2022
Avera Health and Sema4 Announce Data-driven Study to Advance Cancer Treatment Across the Avera Service Area
May 26, 2022
Sema4 to Participate at Two Investor Conferences in June 2022
May 12, 2022
Sema4 Reports First Quarter 2022 Financial Results and Business Highlights
May 4, 2022
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2022
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
Displaying 1 - 10 of 23